Literature DB >> 26185382

Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Prashant Singh1, Kyle Staller1, Kenneth Barshop1, Elaine Dai1, Jennifer Newman1, Sonia Yoon1, Shahar Castel1, Braden Kuo1.   

Abstract

AIM: To determine effect of irritable bowel syndrome (IBS) subtype on IBS-specific quality of life (QOL) questionnaire and its subscales.
METHODS: We studied IBS patients visiting our functional gastroenterology disorder clinic at a tertiary care center of Unites States. IBS and IBS subtype were diagnosed using Rome-III questionnaire. QOL was assessed using IBS-QOL questionnaire. IBS-QOL assesses quality of life along eight subscales: dysphoria, interference with activities, body image, health worry, food avoidance, social reactions, sexual health, and effect on relationships. IBS-QOL and its subscales were both scored on a range of 0-100 with higher scores suggestive of better QOL. Results of overall IBS-QOL scores and subscale scores are expressed as means with 95%CI. We compared mean IBS-QOL score and its subscales among various IBS-subtypes. Analysis of variance (ANOVA) was used to compare the mean difference between more than two groups after controlling for age and gender. A post-hoc analysis using Bonferroni correction was used only when P value for ANOVA was less than 0.05.
RESULTS: Of 542 patients screened, 243 had IBS as per Rome-III criteria. IBS-mixed (IBS-M) was the most common IBS subtype (121 patients, 49.8%) followed by IBS- diarrhea (IBS-D) (56 patients, 23.1%), IBS-constipation (IBS-C) (54 patients, 22.2%) and IBS-unspecified (IBS-U) (12 patients, 4.9%). Overall IBS-QOL scores were significantly different among various IBS-subtypes (P = 0.01). IBS-QOL of patients with IBS-D (61.6, 95%CI: 54.0-69.1) and IBS-M (63.0, 95%CI: 58.1-68.0) was significantly lower than patients with IBS-C (74.5, 95%CI: 66.9-82.1) (P = 0.03 and 0.02 respectively). IBS-D patients scored significantly lower than IBS-C on food avoidance (45.0, 95%CI: 34.8-55.2 vs 61.1, 95%CI: 50.8-71.3, P = 0.04) and interference with activity (59.6, 95%CI: 51.4-67.7 vs 82.3, 95%CI: 74.1-90.6, P < 0.001). IBS-M patients had more interference in their activities (61.6, 95%CI: 56.3-66.9 vs 82.3, 95%CI: 74.1-90.6, P = 0.001) and greater impact on their relationships (73.3, 95%CI: 68.4-78.2 vs 84.7, 95%CI: 77.2-92.2, P = 0.02) than IBS-C patients. Patients with IBS-M also scored significantly lower than IBS-C on food avoidance (47.2, 95%CI: 40.7-53.7 vs 61.1, 95%CI: 50.8-71.3, P = 0.04) and social reaction (66.1, 95%CI: 61.1-71.1 vs 80.0, 95%CI: 72.1-87.7, P = 0.005).
CONCLUSION: IBS-D and IBS-M patients have lower IBS-QOL than IBS-C patients. Clinicians should recognize food avoidance, effects on daily activities and relationship problems in these patients.

Entities:  

Keywords:  Constipation; Diarrhea; Irritable bowel syndrome; Irritable bowel syndrome subtype; Irritable bowel syndrome-quality of life; Quality of life

Mesh:

Year:  2015        PMID: 26185382      PMCID: PMC4499353          DOI: 10.3748/wjg.v21.i26.8103

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences.

Authors:  K W Monsbakken; P O Vandvik; P G Farup
Journal:  Eur J Clin Nutr       Date:  2006-05       Impact factor: 4.016

2.  Impact of irritable bowel syndrome on personal relationships and working practices.

Authors:  D B Silk
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 2.566

3.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

Authors:  Emma P Halmos; Victoria A Power; Susan J Shepherd; Peter R Gibson; Jane G Muir
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

4.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.

Authors:  Fermín Mearin; Agustín Balboa; Xavier Badía; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Montse Roset; Nicholas J Talley
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 2.566

7.  Quality of life of patients with irritable bowel syndrome in Korea.

Authors:  Jae Myung Park; Myung-Gyu Choi; Yong Sung Kim; Chang Hwan Choi; Suck Chei Choi; Su Jin Hong; Jeong Jo Jeong; Dong Ho Lee; Joon Seong Lee; Kwang Jae Lee; Hee Jung Son; In Kyung Sung
Journal:  Qual Life Res       Date:  2009-02-27       Impact factor: 4.147

8.  Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS.

Authors:  F Cremonini; J P Nicandro; V Atkinson; R Shringarpure; E Chuang; A Lembo
Journal:  Aliment Pharmacol Ther       Date:  2012-07-10       Impact factor: 8.171

9.  Prevalence of irritable bowel syndrome: a community based study from northern India.

Authors:  Govind K Makharia; Anil K Verma; Ritvik Amarchand; Anil Goswami; Prashant Singh; Abhishek Agnihotri; Faizul Suhail; Anand Krishnan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

Review 10.  Review article: the economic impact of the irritable bowel syndrome.

Authors:  C Canavan; J West; T Card
Journal:  Aliment Pharmacol Ther       Date:  2014-09-09       Impact factor: 8.171

View more
  27 in total

1.  Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome.

Authors:  Kristen R Weaver; Gail D'Eramo Melkus; Jason Fletcher; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2018-02-05       Impact factor: 2.522

2.  Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.

Authors:  Prashant Singh; Ha-Neul Lee; Vikram Rangan; Sarah Ballou; Joseph Lembo; Jesse Katon; Courtney McMahon; Daniel Friedlander; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-20       Impact factor: 11.382

3.  Novel Therapies in IBS-D Treatment.

Authors:  Judy Nee; Mohammed Zakari; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

Review 4.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

5.  Variable Use of Disaccharidase Assays When Evaluating Abdominal Pain.

Authors:  Stanley A Cohen; Hannah Oloyede
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-01

6.  Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.

Authors:  Sarah Ballou; Courtney McMahon; Ha-Neul Lee; Jesse Katon; Andrea Shin; Vikram Rangan; Prashant Singh; Judy Nee; Michael Camilleri; Anthony Lembo; Johanna Iturrino
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-13       Impact factor: 11.382

Review 7.  The global impact of IBS: time to think about IBS-specific models of care?

Authors:  Maura Corsetti; Peter Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2017-07-31       Impact factor: 4.409

Review 8.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

9.  Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life.

Authors:  Joelle BouSaba; Wassel Sannaa; Sanna McKinzie; Priya Vijayvargiya; Victor Chedid; Xiao Jing Wang; Jessica Atieh; Ting Zheng; Justin Brandler; Ann L Taylor; Irene Busciglio; W Scott Harmsen; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-04       Impact factor: 13.576

10.  Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial.

Authors:  Hamidreza Kianifar; Seyed Ali Jafari; Mohammadali Kiani; Hamid Ahanchian; Seyed Vahid Ghasemi; Zubin Grover; Leili Zarif Mahmoodi; Rita Bagherian; Maryam Khalesi
Journal:  Electron Physician       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.